FindTrial
Sign In

Clinical Research on the Relationship between GZMB, P53 in Gastric Cancer Tissues and Patient Prognosis

Clinical Research on the Relationship between GZMB, P53 in Gastric Cancer Tissues and Patient Prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128792
Enrollment
Unknown
Registered
2026-07-26
Start date
2022-07-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Observation group:NA

Sponsors

The First People's Hospital of NanYang
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Postoperative pathological diagnosis confirmed as stage II or III gastric adenocarcinoma; 2.Underwent D2 radical gastrectomy for gastric cancer; 3.Did not receive neoadjuvant chemotherapy before surgery; 4.All are patients with initial diagnosis;

Exclusion criteria

Exclusion criteria: 1.Concurrent with other tumors; 2.Concurrent with infectious diseases; 3.Concurrent with immune system diseases; 4.Concurrent with severe cardiovascular and cerebrovascular diseases;

Design outcomes

Primary

MeasureTime frame
GZMB;P53 expression level;—

Secondary

MeasureTime frame
Progression-Free Survival, PFS;—

Countries

China

Contacts

Public ContactMa Lei

The First People's Hospital of NanYang

nysyyllh@163.com+86 377 63310089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026